HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined bevacizumab and triamcinolone acetonide injections for macular edema in a patient with astrocytic hamartomas and tuberous sclerosis.

Abstract
Retinal astrocytic hamartoma or retinal astrocytoma is the best-known ocular manifestation of tuberous sclerosis complex, a neurocutaneous syndrome characterized by the development of multiple disseminated hamartomas. It can have several clinical presentations, ranging from unilateral transparent, noncalcified lesions to bilateral multinodular, mulberry-like calcified tumors. Symptoms appear if the tumor involves the macula and can cause visual loss on the basis of progressive retinal degeneration. The authors report a case of a patient with tuberous sclerosis, bilateral astrocytic hamartomas, and macular edema with intraretinal hemorrhage in the left eye that has responded well to treatment with bevacizumab and intravitreal triamcinolone acetonide.
AuthorsMarcela Lonngi, Aaron S Gold, Timothy G Murray
JournalOphthalmic surgery, lasers & imaging retina (Ophthalmic Surg Lasers Imaging Retina) 2013 Jan-Feb Vol. 44 Issue 1 Pg. 85-90 ISSN: 2325-8179 [Electronic] United States
PMID23410814 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright 2013, SLACK Incorporated.
Chemical References
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Triamcinolone Acetonide
Topics
  • Adolescent
  • Angiogenesis Inhibitors (therapeutic use)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Bevacizumab
  • Drug Therapy, Combination
  • Female
  • Fluorescein Angiography
  • Glucocorticoids (therapeutic use)
  • Hamartoma (diagnosis, drug therapy)
  • Humans
  • Intravitreal Injections
  • Macular Edema (diagnosis, drug therapy)
  • Retinal Diseases (diagnosis, drug therapy)
  • Tomography, Optical Coherence
  • Triamcinolone Acetonide (therapeutic use)
  • Tuberous Sclerosis (diagnosis, drug therapy)
  • Vascular Endothelial Growth Factor A (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: